Skip to main content
Cibus, Inc. (CBUS)
NASDAQ: CBUS · IEX Real-Time Price · USD
16.74
0.00 (0.00%)
At close: May 3, 2024, 4:00 PM
17.32
+0.58 (3.46%)
After-hours: May 3, 2024, 4:11 PM EDT

Cibus Revenue

In the year 2023, Cibus had annual revenue of $1.82M with 1,057.32% growth. Revenue in the quarter ending December 31, 2023 was $1.10M with 2,526.19% year-over-year growth.

Revenue (ttm)
$1.82M
Revenue Growth
+1,057.32%
P/S Ratio
232.52
Revenue / Employee
$9,929
Employees
183
Market Cap
422.50M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.82M1.66M1,057.32%
Dec 31, 2022157.00K-25.83M-99.40%
Dec 31, 202125.99M2.14M8.96%
Dec 31, 202023.85M16.56M226.91%
Dec 31, 20197.30M7.06M2,991.53%
Dec 31, 2018236.00K-272.00K-53.54%
Dec 31, 2017508.00K109.00K27.32%
Dec 31, 2016399.00K-873.00K-68.63%
Dec 31, 20151.27M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ZimVie 457.43M
Anika Therapeutics 166.66M
Cartesian Therapeutics 26.00M
iTeos Therapeutics 12.60M
Lexicon Pharmaceuticals 2.31M
Revenue Rankings

CBUS News

More News